Article Type
Original Research
Published
The objective of this study was to assess the impact of dupilumab on chronic cough in patients with severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps.
Original Research
The objective of this study was to assess the impact of dupilumab on chronic cough in patients with severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps.
Case Report & Review
This case report describes a 69-year-old male with severe, poorly controlled asthma who was diagnosed with eosinophilic granulomatosis with polyangiitis, it also presents a review of the literature on eosinophilic granulomatosis with polyangiitis and asthma management.
Review
This narrative review aims to frame the evolution of the debated concept of clinical remission as an ambitious and now concretely achievable outcome in modern asthma management, to highlight correct management of inhaled therapies, oral corticosteroids and biological drugs in this context, and, finally, to provide clinicians with insights that could be useful to achieve remission in the greatest possible number of patients.
Case Series
This article aims to report very long-term data of patients with severe eosinophilic asthma assessing asthma control, lung function, inhaled corticosteroid dose reduction and clinical and biological parameters of patients treated with mepolizumab.
Review
This article describes a case of severe hypereosinophilia in a patient with chronic rhinosinusitis with nasal polyps and asthma treated with dupilumab and a subsequent therapeutic shift to mepolizumab that led to maintenance of symptom control and concomitant normalization of blood eosinophil count.